β1-adrenergic receptor autoantibodies from heart failure patients enhanced TNF-α secretion in RAW264.7 macrophages in a largely PKA-dependent fashion

Journal of Cellular Biochemistry

Volumn 113, Issue 10, 2012, Pages 3218-3228

  Du, Yunhui ^a   Yan, Li ^b   Du, Hongwei ^c   Wang, Li ^d   Ding, Fan ^b   Quan, Lin ^a   Cheng, Xiuli ^b   Song, Kai ^e   Liu, Huirong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c Department of Internal Medicine   (China)

^d SHANXI MEDICAL UNIVERSITY   (China)

^e CHANGZHI MEDICAL COLLEGE   (China)

Author keywords

autoantibody; heart failure; macrophage; Receptor, adrenergic, BETA 1; TNF alpha

Indexed keywords

AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CHOLECYSTOKININ OCTAPEPTIDE; METOPROLOL; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANIMAL CELL; ANTIBODY ISOLATION; ARTICLE; BLOOD SAMPLING; CELL ASSAY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMAN; IN VITRO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; WESTERN BLOTTING;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELL LINE; CELL PROLIFERATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HUMANS; MACROPHAGES; METOPROLOL; MICE; MICROFILAMENT PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; REAGENT KITS, DIAGNOSTIC; RECEPTORS, ADRENERGIC, BETA-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864984111     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24198     Document Type: Article

References (45)

1. Aandahl EM, Moretto WJ, Haslett PA, Vang T, Bryn T, Tasken K, Nixon DF,. 2002. Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J Immunol 169: 802-808.
2. Arndt-Marić R, Nägele H, Schewe G, Kromminga A,. 2010. Are autoantibodies against the beta1-adrenergic receptor markers for dilated cardiomyopathy? Clin Lab 56 (11-12): 519-526.
3. Avni D, Ernst O, Philosph A, Zor T,. 2010. Role of CREB in modulation of TNF-alpha and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Molecular Immunology 47: 1396-1403.
4. Byrkjeland R, Nilsson BB, Westheim AS, Arnesen H, Seljeflot I,. 2011. Inflammatory markers as related to disease severity in patients with chronic heart failure: Limited effects of exercise training. Scand J Clin Lab Invest 71 (7): 598-605.
5. Cáceres LC, Bonacci GR, Sánchez MC, Chiabrando GA,. 2010. Activated α(2) macroglobulin induces matrix metalloproteinase 9 expression by low-density lipoprotein receptor-related protein 1 through MAPK-ERK1/2 and NF-κB activation in macrophage-derived cell lines. J Cell Biochem 111 (3): 607-617.
6. Chen Z, Jiang H, Wan Y, Bi C, Yuan Y,. 2012. H(2)O (2)-induced secretion of tumor necrosis factor-α evokes apoptosis of cardiac myocytes through reactive oxygen species-dependent activation of p38 MAPK. Cytotechnology 64 (1): 65-73.
7. Chiale PA, Rosenbaum MB, Elizari MV, Hjalmarson A, Magnusson Y, Wallukat G, Hoebeke J,. 1995. High prevalency of antibodies against beta-1 and beta-2 adrenoceptors in patients with primary electrical cardiac abnormalities. J Am Coll Cardial 26: 864-869.
8. Cho EJ, An HJ, Shin JS, Choi HE, Ko J, Cho YW, Kim HM, Choi JH, Lee KT,. 2011. Roxatidine suppresses inflammatory responses via inhibition of NF-κB and p38 MAPK activation in LPS-induced RAW 264.7 macrophages. J Cell Biochem 112 (12): 3648-3659.
9. Dohlman HG, Caron MG, DeBlasi A, Frielle T, Lefkowitz RJ,. 1990. Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta2-adrenergic receptor. Biochemistry 29: 2335-2342.
10. Ganapathy V, Gurlo T, Jarstadmarken HO, von Grafenstein H,. 2000. Regulation of TCR-induced IFN-gamma release from islet-reactive non-obese diabetic CD8(+) T cells by prostaglandin E(2) receptor signaling. Int Immunol 12: 851-860.
11. Gerlo S, Kooijman R, Beck IM, Kolmus K, Spooren A, Haegeman G,. 2011. Cyclic AMP: A selective modulator of NF-κB action. Cell Mol Life Sci 68 (23): 3823-3841.
12. Guha M, Mackman N,. 2001. LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94.
13. 1-subtype. Cell Physiol Biochem 28 (2): 315-322.
14. Hamad AM, Clayton A, Islam B, Knox AJ,. 2003. Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function. Am J Physiol Lung Cell Mol Physiol 285: 973-983.
15. Hasko G, Shanley TP, Egnaczyk G, Nemeth ZH, Salzman AL, Sylvester E, Szabo C,. 1998. Exgenous and endogenous cathecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenergic receptor mediated mechanism. Br J Pharmacol 125: 1297-1303.
16. Hu Y, Zhang H, Lu Y, Bai H, Xu Y, Zhu X, Zhou R, Ben J, Xu Y, Chen Q,. 2011. Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization. Basic Res Cardiol 106 (6): 1311-1328.
17. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F,. 1999. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 99: 649-654.
18. Jane-wit D, Altuntas CZ, Johnson JM, Yong S, Wickley PJ, Clark P, Wang Q, Popović ZB, Penn MS, Damron DS, Perez DM, Tuohy VK,. 2007. Beta1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation 116: 399-410.
19. Lee JY, Kim JH, Chae G, Lee BK, Ha KS, Kwon YG, Kim YM,. 2010. Cyclic AMP prolongs graft survival by suppressing apoptosis and inflammatory gene expression in acute cardiac allograft rejection. Exp Mol Med 42 (1): 69-79.
20. Levine B, Kalman J, Mayer L, Fillit HM, Packer M,. 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (4): 236-241.
21. Liu HR, Zhao RR, Zhi JM, Wu BM, Fu ML,. 1999. Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. Autoimmunity 29 (1): 43-51.
22. Magnusson Y, Hoyer S, Lengagne R, Chapot MP, Guillet JG, Hjalmarson A, Strosberg AD, Hoebeke J,. 1989. Antigenic analysis of the second extracellular loop of the human beta-adrenergic receptors. Clin Exp Immunol 78: 42-48.
23. Magnusson Y, Marullo S, Hoyer S, Waagstein F, Andersson B, Vahlne A, Guillet JG, Strosberg AD, Hjalmarson A, Hoebeke J,. 1990. Mapping of a functional autoimmune epitope on the beta1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 86: 1658-1663.
24. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J,. 1994. Autoimmunity in idiopathic dilated cardiomyopathy: Characterization of antibodies against the beta1-adrenoceptor with positive chronotropic effect. Circulation 89: 2760-2767.
25. Miao GB, Liu JC, Liu MB, Wu JL, Zhang G, Chang J, Zhang L,. 2006. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment. Eur J Clin Invest 36 (9): 614-620.
26. Morimoto Y, Kikuchi K, Ito T, Tokuda M, Matsuyama T, Noma S, Hashiguchi T, Torii M, Maruyama I, Kawahara K,. 2009. MK615 attenuates Porphyromonas gingivalis lipopolysaccharide-induced pro-inflammatory cytokine release via MAPK inactivation in murine macrophage-like RAW264.7 cells. Biochem Biophys Res Commun 389: 90-94.
27. Nagatomo Y, Yoshikawa T, Kohno T, Yoshizawa A, Baba A, Anzai T, Meguro T, Satoh T, Ogawa S,. 2009. A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure. J Card Fail 15 (3): 224-232.
28. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, Mukundan L, Brombacher F, Locksley RM, Chawla A,. 2011. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480 (7375): 104-108.
29. Pérez AR, Fontanella GH, Nocito AL, Revelli S, Bottasso OA,. 2009. Short treatment with the tumour necrosis factor-alpha blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation. Clin Exp Immunol 157 (2): 291-299.
30. Podlowski S, Luther HP, Morwinski R, Müller J, Wallukat G,. 1998. Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes. Circulation 98 (22): 2470-2476.
31. Robinet A, Hoizey G, Millart H,. 2005. PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning. Cardiovascular Research 66 (3): 530-542.
32. Sartoretto JL, Jin BY, Bauer M, Gertler FB, Liao R, Michel T,. 2009. Regulation of VASP phosphorylation in cardiac myocytes: Differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart. Am J Physiol Heart Circ Physiol 297 (5): H1697-H1710.
33. Smith JA, Das A, Ray SK, Banik NL,. 2012. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87 (1): 10-20.
34. Smolenski A, Bachmann C, Reinhard K, Hönig-Liedl P, Jarchau T, Hoschuetzky H, Walter U,. 1998. Analysis and regulation of vasodilator- stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 273: 20029-20035.
35. Stankovic-Popovic V, Nesic V, Popovic D, Maksic D, Colic M, Vasilijic S, Vucinic Z, Milicic B, Radjen S, Dimkovic N,. 2011. Effects of conventional versus biocompatible peritoneal dialysis solutions on peritoneal and systemic inflammation, malnutrition and atherosclerosis in CAPD patients. Clin Nephrol 76 (4): 314-322.
36. Sun J, Kim SJ, Park MK, Kim HJ, Tsoy I, Kang YJ, Lee YS, Seo HG, Lee JH, Chang KC,. 2005. Selective activation of adrenergic beta1 receptors induces heme oxygenase 1 production in RAW264.7 cells. FEBS Letter 579: 5494-5500.
37. Tsarouhas K, Tsitsimpikou C, Haliassos A, Georgoulias P, Koutsioras I, Kouretas D, Kogias J, Liosis I, Rentoukas E, Kyriakides Z,. 2011. Study of insulin resistance, TNF-α, total antioxidant capacity and lipid profile in patients with chronic heart failure under exercise. In Vivo 25 (6): 1031-1037.
38. Tutor AS, Penela P, Mayor F Jr., 2007. Anti-β1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells. Cardiovascular Research 76: 51-60.
39. Wallukat G, Morwinski M, Kowal K, Förster A, Boewer V, Wollenberger A,. 1991. Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: Beta-adrenergic agonism without desensitization. Eur Heart J 12 (Suppl D): 178-181.
40. Wallukat G, Müller J, Podlowski S, Nissen E, Morwinski R, Hetzer R,. 1999. Agonist-like beta-adrenoceptor antibodies in heart failure. Am J Cardiol 83 (12A): 75H-79H.
41. Wallukat G, Wollenberger A,. 1987. Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes. Biomed Biochim Acta 46 (8-9): S634-S639.
42. Wang RP, Yao Q, Xiao YB, Zhu SB, Yang L, Feng JM, Li DZ, Li XL, Wu JJ, Chen J,. 2011. Toll-like receptor 4/nuclear factor-kappa B pathway is involved in myocardial injury in a rat chronic stress model. Stress 14 (5): 567-575.
43. Wiedermann CJ, Beimpold H, Herold M, Knapp E, Braunsteiner H,. 1993. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol 22 (7): 1897-1901.
44. Zinyama RB, Bancroft GJ, Sigola LB,. 2001. Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10. Immunology 104 (4): 439-446.
45. Zuo L, Bao H, Tian J, Wang X, Zhang S, He Z, Yan L, Zhao R, Ma X, Liu H,. 2010. Long-term active immunization with a synthetic peptide corresponding to the second extracellular loop of beta(1)-adrenoceptor induces both morphological and functional cardiomyopathic changes in rats. Int J Cardiol 149 (1): 89-94.